Current Report Filing (8-k)
27 April 2022 - 11:37PM
Edgar (US Regulatory)
false000183233200018323322022-04-272022-04-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
|
Date of Report (Date of earliest event reported):
April 27, 2022
|
Aveanna Healthcare Holdings Inc.
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
|
|
Delaware
|
001-40362
|
81-4717209
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
|
400 Interstate North Parkway SE
|
|
|
Atlanta,
Georgia
|
|
30339
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
Registrant’s Telephone Number, Including Area Code:
770
441-1580
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.01 per share
|
|
AVAH
|
|
The NASDAQ Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§ 230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 7.01 Regulation FD Disclosure.
On April 27, 2022, Aveanna Healthcare Holdings, Inc. (the
"Company", "we", "us", or "our") made available a financial
presentation to investors for a series of investor conferences. A
copy of the presentation is attached hereto as Exhibit 99.1 and
incorporated by reference in this Item 7.01. A copy of the
presentation is also available on our website at
ir.aveanna.com.
Use of our Website and Social Media to Distribute Material Company
Information
We use our website as a channel of distribution for important
Company information. We routinely post on our website important
information, including press releases, investor presentations and
financial information, which may be accessed by clicking on the
“Investors” section of www.aveanna.com. We also use our website to
expedite public access to time-critical information regarding our
Company in advance of or in lieu of distributing a press release or
a filing with the SEC disclosing the same information. Therefore,
investors should look to the “Investors” section of our website for
important and time-critical information. Visitors to our website
can also register to receive automatic e-mail and other
notifications alerting them when certain new information is made
available on our website. Information contained on, or accessible
through, our website is not a part of and is not incorporated by
reference in this Current Report on Form 8-K.
The information contained in this Item 7.01, including in Exhibit
99.1 attached hereto, is “furnished” and not “filed” for purposes
of Section 18 of the Exchange Act or otherwise subject to the
liabilities of that section. Such information shall not be
incorporated by reference in another filing under the Exchange Act
or the Securities Act, except to the extent such other filing
specifically incorporates such information by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
AVEANNA HEALTHCARE HOLDINGS INC.
|
|
|
|
|
|
|
Date:
|
April 27, 2022
|
By:
|
/s/ David Afshar
|
|
|
|
|
David Afshar
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
Aveanna Healthcare (NASDAQ:AVAH)
Historical Stock Chart
From May 2022 to Jun 2022
Aveanna Healthcare (NASDAQ:AVAH)
Historical Stock Chart
From Jun 2021 to Jun 2022
